Wayfinding Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
5,946
-340
| -5% | -$67K | 0.52% | 37 |
|
|
2025
Q1 | $1.32M | Sell |
6,286
-53
| -0.8% | -$11.1K | 0.58% | 33 |
|
|
2024
Q4 | $1.13M | Buy |
+6,339
| New | +$1.13M | 0.6% | 34 |
|
|
2024
Q3 | – | Sell |
-6,656
| Closed | -$1.14M | – | 38 |
|
|
2024
Q2 | $1.14M | Sell |
6,656
-36
| -0.5% | -$6.17K | 0.64% | 32 |
|
|
2024
Q1 | $1.07M | Buy |
6,692
+153
| +2% | +$24.5K | 0.63% | 33 |
|
|
2023
Q4 | $1.01M | Buy |
6,539
+19
| +0.3% | +$2.94K | 0.69% | 32 |
|
|
2023
Q3 | $966K | Buy |
6,520
+117
| +2% | +$17.3K | 0.73% | 29 |
|
|
2023
Q2 | $965K | Sell |
6,403
-160
| -2% | -$24.1K | 0.67% | 28 |
|
|
2023
Q1 | $1.05M | Buy |
6,563
+553
| +9% | +$88.1K | 0.8% | 23 |
|
|
2022
Q4 | $817K | Sell |
6,010
-262
| -4% | -$35.6K | 0.66% | 30 |
|
|
2022
Q3 | $841K | Buy |
6,272
+21
| +0.3% | +$2.82K | 0.79% | 22 |
|
|
2022
Q2 | $957K | Buy |
6,251
+3
| +0% | +$459 | 0.84% | 21 |
|
|
2022
Q1 | $954K | Buy |
6,248
+238
| +4% | +$36.3K | 0.8% | 20 |
|
|
2021
Q4 | $817K | Buy |
+6,010
| New | +$817K | 0.66% | 30 |
|